342 related articles for article (PubMed ID: 25962896)
1. Sarcopenia--The search for emerging biomarkers.
Kalinkovich A; Livshits G
Ageing Res Rev; 2015 Jul; 22():58-71. PubMed ID: 25962896
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women.
Hofmann M; Halper B; Oesen S; Franzke B; Stuparits P; Tschan H; Bachl N; Strasser EM; Quittan M; Ploder M; Wagner KH; Wessner B
Exp Gerontol; 2015 Apr; 64():35-45. PubMed ID: 25681638
[TBL] [Abstract][Full Text] [Related]
3. Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells.
Bowser M; Herberg S; Arounleut P; Shi X; Fulzele S; Hill WD; Isales CM; Hamrick MW
Exp Gerontol; 2013 Feb; 48(2):290-7. PubMed ID: 23178301
[TBL] [Abstract][Full Text] [Related]
4. TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice.
Pan C; Singh S; Sahasrabudhe DM; Chakkalakal JV; Krolewski JJ; Nastiuk KL
Endocrinology; 2016 Nov; 157(11):4461-4472. PubMed ID: 27611336
[TBL] [Abstract][Full Text] [Related]
5. Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia.
Bütikofer L; Zurlinden A; Bolliger MF; Kunz B; Sonderegger P
FASEB J; 2011 Dec; 25(12):4378-93. PubMed ID: 21885656
[TBL] [Abstract][Full Text] [Related]
6. A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved.
Moreira-Pais A; Ferreira R; Oliveira PA; Duarte JA
Geroscience; 2022 Jun; 44(3):1199-1213. PubMed ID: 34981273
[TBL] [Abstract][Full Text] [Related]
7. C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction.
Drey M; Sieber CC; Bauer JM; Uter W; Dahinden P; Fariello RG; Vrijbloed JW;
Exp Gerontol; 2013 Jan; 48(1):76-80. PubMed ID: 22683512
[TBL] [Abstract][Full Text] [Related]
8. Bone Morphogenetic Proteins and myostatin pathways: key mediator of human sarcopenia.
Scimeca M; Piccirilli E; Mastrangeli F; Rao C; Feola M; Orlandi A; Gasbarra E; Bonanno E; Tarantino U
J Transl Med; 2017 Feb; 15(1):34. PubMed ID: 28202082
[TBL] [Abstract][Full Text] [Related]
9. Personalized risk assessment of heart failure patients: more perspectives from transforming growth factor super-family members.
Goletti S; Gruson D
Clin Chim Acta; 2015 Mar; 443():94-9. PubMed ID: 25260834
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients.
Hettwer S; Dahinden P; Kucsera S; Farina C; Ahmed S; Fariello R; Drey M; Sieber CC; Vrijbloed JW
Exp Gerontol; 2013 Jan; 48(1):69-75. PubMed ID: 22433628
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia: a histological and immunohistochemical study on age-related muscle impairment.
Tarantino U; Scimeca M; Piccirilli E; Tancredi V; Baldi J; Gasbarra E; Bonanno E
Aging Clin Exp Res; 2015 Oct; 27 Suppl 1():S51-60. PubMed ID: 26197719
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients.
Marzetti E; Calvani R; Lorenzi M; Marini F; D'Angelo E; Martone AM; Celi M; Tosato M; Bernabei R; Landi F
Exp Gerontol; 2014 Dec; 60():79-82. PubMed ID: 25304331
[TBL] [Abstract][Full Text] [Related]
13. C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review.
Monti E; Sarto F; Sartori R; Zanchettin G; Löfler S; Kern H; Narici MV; Zampieri S
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):730-744. PubMed ID: 36772862
[TBL] [Abstract][Full Text] [Related]
14. The Interplay between Mitochondrial Morphology and Myomitokines in Aging Sarcopenia.
Romanello V
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374852
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Sarcopenia Using Biomarkers of the Neuromuscular Junction in Parkinson's Disease.
Karim A; Iqbal MS; Muhammad T; Qaisar R
J Mol Neurosci; 2022 Apr; 72(4):820-829. PubMed ID: 35044622
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting.
Tintignac LA; Brenner HR; Rüegg MA
Physiol Rev; 2015 Jul; 95(3):809-52. PubMed ID: 26109340
[TBL] [Abstract][Full Text] [Related]
17. Myostatin and sarcopenia: opportunities and challenges - a mini-review.
White TA; LeBrasseur NK
Gerontology; 2014; 60(4):289-93. PubMed ID: 24457615
[TBL] [Abstract][Full Text] [Related]
18. Voluntary wheel running with and without follistatin overexpression improves NMJ transmission but not motor unit loss in late life of C57BL/6J mice.
Chugh D; Iyer CC; Bobbili P; Blatnik AJ; Kaspar BK; Meyer K; Burghes AH; Clark BC; Arnold WD
Neurobiol Aging; 2021 May; 101():285-296. PubMed ID: 33678425
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
[TBL] [Abstract][Full Text] [Related]
20. Active older dancers have lower C-terminal Agrin fragment concentration, better balance and gait performance than sedentary peers.
Marcolin G; Franchi MV; Monti E; Pizzichemi M; Sarto F; Sirago G; Paoli A; Maggio M; Zampieri S; Narici M
Exp Gerontol; 2021 Oct; 153():111469. PubMed ID: 34246731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
